Abstract: A composition is provided comprising: a) polyvinylchloride, b) inorganic solid particles, and c) a polymer having a polyether segment, wherein at least 60 mol-% of the end groups of the polymer are selected from the group consisting of carboxylic acid groups and hydroxyl groups, and wherein at least a part of the end groups of the polymer is a carboxylic acid group, wherein the carboxylic acid end groups are linked to the polyether segment via a linking segment comprising an ester group.

Abstract: A cleaning device for a vehicle, with which at least one cleaning location is cleaned with pressurized cleaning liquid and/or pressurized ambient air, is proposed, including: a pump-compressor stage for sucking up and conveying the cleaning liquid and/or the ambient air, a fluid path which fluidically connects the pump-compressor stage upstream to a cleaning liquid tank and to an environment of the cleaning device, and a fluid distribution apparatus downstream of the pump-compressor stage, which is fed with the cleaning liquid and/or the ambient air by the pump-compressor stage, the fluid distribution apparatus being fluidically connected to the cleaning location. A vehicle with such a cleaning device, the first and the second use, and a cleaning method for a vehicle are also proposed.

Abstract: An actuator for a side door of a motor vehicle is described, which brings about automatic opening or closing of the side door depending on a signal and has a device for holding the side door in any open position. The holding device is realized by a function of the electric motor itself, according to which function the control device initiates a short-circuit function of the motor phases when the motor is activated, which causes a high current flow and thus a high torque for holding the side door open. By short-circuiting the motor phases, no additional components are required, since this is a special activation function of the motor.

Abstract: An actuator for a side door of a motor vehicle is described. The actuator brings about automatic opening or closing of the side door depending on a signal. The actuator has an electric motor which, depending on an activation, generates a torque which acts on a hinge of the side door via a transmission. Furthermore, it has a device for holding the side door in any open position, which holding device is realized by a function of the electric motor itself which is designed in such a way that, in the currentless state, it has an increased cogging torque which is configured to a value required as a holding torque for holding the door open. In this way, the actuator is distinguished by a simple and inexpensive design.

Abstract: The present invention is related to agonist of adiponectin receptor 1 (AdipoR1) and/or adiponectin receptor 2 (AdipoR2) for the treatment and/or prevention of polycystic ovary syndrome (PCOS).

Abstract: A rotor unit for an electric machine may include at least one rotor carrier and a plurality of substantially identical rotor segments. Each of the plurality of rotor segments may include at least one recess through which the rotor carrier is passable. A plurality of axial slot portions may be disposed spaced apart from one another in a circumferential direction along a circumferential contour of the at least one recess. The rotor carrier may include a guide portion that engages in a slot portion of each rotor segment providing a non-rotatable connection therebetween. Via selection of the slot portion of the rotor segment in which the guide portion engages, discrete angular positions of the rotor segment about an axial axis of the rotor carrier may be selectable. The plurality of rotor segments may be arranged in different angular positions about the axial axis of the rotor carrier.

Abstract: An annular stator of an electric motor may include rectangular hairpin stator coils extending in a radial direction and having a rectangular copper wire, rectangular stator teeth arranged in a circumferential direction between two adjacent hairpin stator coils, such that a wedge-shaped interspace may be between each hairpin stator coil and an adjacent stator tooth, and a heat-transmitter arranged on each of two longitudinal sides of each hairpin stator coil, at least partially filling the wedge-shaped interspace and connecting the respective hairpin stator coil to the adjacent stator tooth in a heat-transmitting manner.

Abstract: The invention relates to N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides, intermediates and methods for their production, use thereof for treating and/or preventing diseases and use thereof for producing medicinal products and use thereof for treating and/or preventing diseases, especially of hyperproliferative diseases.

Abstract: The invention relates to N-[4-(quinolin-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides, intermediates and methods for their production, use thereof for treating and/or preventing diseases and use thereof for producing medicinal products and use thereof for treating and/or preventing diseases, especially of hyperproliferative diseases.

Abstract: The invention refers to the use of androgen receptor antagonists for the treatment and/or prevention of fibroids, also known as uterine leiomyoma, leiomyomata. Particularly, the invention refers to the use of an androgen receptor antagonist being any one of the compounds according to the following list: cyproterone acetate, oxendolone, chlormadinone acetate, spironolactone, osaterone acetate, dienogest, flutamide, hydroxyflutamide, nilutamide, bicalutamide, RU 58841, LGD-2226, MDV3100, BMS-641988, BMS-779333, or 4-(3-{[6-(2-hydroxy-2-methylpropoxy)pyridin-3-yl]methyl}-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile (thioxoimidazolidine derivative) for the treatment of fibroids.

Abstract: The present invention relates to the use of a pharmaceutical composition which comprises as active component at least one HipK4 nucleic acid, a HipK4 polypeptide, modulators of HipK4, antibodies directed against HipK4, a HipK4 antisense, and a HipK4 RNAi, for the diagnosis and treatment of fertility impairments and for contraception. The invention further relates to the use of this pharmaceutical composition for manufacturing a medicament for the treatment of fertility impairments.

Abstract: The present invention relates to azaindoles of general formula I, a method for the production thereof, and to the use thereof for the production of pharmaceutical compositions.

Abstract: The invention relates to compounds of general formula I as well as the production and use thereof as a medication.

Abstract: The invention relates to compounds of general Formula I, the production thereof, and the use thereof as a medicinal product.

Abstract: The invention relates to compounds of general formula I as well as their production and use as a medication.

Abstract: The invention relates to compounds of general formula I as well as the production and use thereof as a medication.

Abstract: The invention relates to compounds of general formula I as well as the production and use thereof as a medication.

Abstract: The invention relates to compounds of general formula I as well as the production and use thereof as a medication.

Abstract: The invention relates to compounds of general Formula I, the production thereof, and the use thereof as a medicinal product.

Abstract: The invention relates to compounds of general formula I as well as their production and use as a medication.